UniSA students can apply for up to $50,000 for startup funding!
+ READ MORE
University of South Australia researchers are developing new technology to reduce the risk of post-operative infection in biomedical implants such as hip and knee replacements.
LipoCeramic Drug Delivery
Spin-out company Ceridia commercialises the LipoCeramic drug delivery technology.
+ VISIT WEBSITE
Novel class of 14-3-3 targeting anti-cancer drugs.
Ability to identify a new class of anticancer drugs based on the capacity to disrupt 14-3-3 dimers.
UniSA leads information innovation
Tell us about your invention
Tell us about your needs